Q7L0J3 (SV2A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 98.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Synaptic vesicle glycoprotein 2A | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 742 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles By similarity. |
| Subunit structure | Interacts with SYT1/synaptotagmin-1 in a calcium-dependent manner. Binds the adapter protein complex AP-2 By similarity. |
| Subcellular location | Cytoplasmic vesicle › secretory vesicle › synaptic vesicle membrane; Multi-pass membrane protein By similarity. Note: Enriched in chromaffin granules, not present in adrenal microsomes. Associated with both insulin granules and synaptic-like microvesicles in insulin-secreting cells of the pancreas By similarity. |
| Post-translational modification | Phosphorylation by CK1 of the N-terminal cytoplasmic domain regulates interaction with SYT1 By similarity. N-glycosylated By similarity. |
| Miscellaneous | Identified as the brain binding-site for the antiepileptic drug levetiracetam/lev. |
| Sequence similarities | Belongs to the major facilitator superfamily. |
| Sequence caution | The sequence BAA34456.2 differs from that shown. Reason: Erroneous initiation. The sequence CAI12573.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q7L0J3-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q7L0J3-2) The sequence of this isoform differs from the canonical sequence as follows: 683-742: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 742 | 742 | Synaptic vesicle glycoprotein 2A | PRO_0000239764 | |||||
Regions | |||||||||
| Topological domain | 1 – 169 | 169 | Cytoplasmic Potential | ||||||
| Transmembrane | 170 – 190 | 21 | Helical; Potential | ||||||
| Topological domain | 191 – 205 | 15 | Extracellular Potential | ||||||
| Transmembrane | 206 – 226 | 21 | Helical; Potential | ||||||
| Topological domain | 227 – 233 | 7 | Cytoplasmic Potential | ||||||
| Transmembrane | 234 – 254 | 21 | Helical; Potential | ||||||
| Topological domain | 255 – 262 | 8 | Extracellular Potential | ||||||
| Transmembrane | 263 – 283 | 21 | Helical; Potential | ||||||
| Topological domain | 284 – 294 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 295 – 315 | 21 | Helical; Potential | ||||||
| Topological domain | 316 – 334 | 19 | Extracellular Potential | ||||||
| Transmembrane | 335 – 355 | 21 | Helical; Potential | ||||||
| Topological domain | 356 – 447 | 92 | Cytoplasmic Potential | ||||||
| Transmembrane | 448 – 468 | 21 | Helical; Potential | ||||||
| Topological domain | 469 – 598 | 130 | Extracellular Potential | ||||||
| Transmembrane | 599 – 619 | 21 | Helical; Potential | ||||||
| Topological domain | 620 – 626 | 7 | Cytoplasmic Potential | ||||||
| Transmembrane | 627 – 647 | 21 | Helical; Potential | ||||||
| Topological domain | 648 – 651 | 4 | Extracellular Potential | ||||||
| Transmembrane | 652 – 672 | 21 | Helical; Potential | ||||||
| Topological domain | 673 – 685 | 13 | Cytoplasmic Potential | ||||||
| Transmembrane | 686 – 708 | 23 | Helical; Potential | ||||||
| Topological domain | 709 – 712 | 4 | Extracellular Potential | ||||||
| Transmembrane | 713 – 731 | 19 | Helical; Potential | ||||||
| Topological domain | 732 – 742 | 11 | Cytoplasmic Potential | ||||||
| Region | 1 – 57 | 57 | Interaction with SYT1 By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 65 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 66 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 80 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 81 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 84 | 1 | Phosphothreonine Ref.9 | ||||||
| Modified residue | 127 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 480 | 1 | Phosphotyrosine By similarity | ||||||
| Glycosylation | 498 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 548 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 573 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 683 – 742 | 60 | Missing in isoform 2. | VSP_019265 | |||||
Experimental info | |||||||||
| Sequence conflict | 100 | 1 | G → D in CAD97824. Ref.4 | ||||||
| Sequence conflict | 404 | 1 | D → G in BAC11645. Ref.3 | ||||||
| Sequence conflict | 493 | 1 | E → G in CAD97824. Ref.4 | ||||||
| Sequence conflict | 524 | 1 | V → A in BAC11645. Ref.3 | ||||||
| Sequence conflict | 544 | 1 | T → A in BAC11645. Ref.3 | ||||||
| Sequence conflict | 582 | 1 | G → D in BAC11645. Ref.3 | ||||||
| Sequence conflict | 611 | 1 | G → R in BAC11645. Ref.3 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 5:277-286(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [2] | Ohara O., Suyama M., Nagase T., Ishikawa K., Kikuno R. Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION. |
| [3] | "Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries." Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J., Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S., Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y. Isogai T.DNA Res. 12:117-126(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Teratocarcinoma. |
| [4] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Retina. |
| [5] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain and Ovary. |
| [8] | "The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam." Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., Fuks B. Proc. Natl. Acad. Sci. U.S.A. 101:9861-9866(2004) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION AS BINDING-SITE FOR ANTIEPILEPTIC DRUG LEVETIRACETAM. |
| [9] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80; SER-81 AND THR-84, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB018279 mRNA. Translation: BAA34456.2. Different initiation. AK075480 mRNA. Translation: BAC11645.1. BX537754 mRNA. Translation: CAD97824.1. AL591493 Genomic DNA. Translation: CAI12572.1. AL591493 Genomic DNA. Translation: CAI12573.1. Sequence problems. CH471121 Genomic DNA. Translation: EAW53596.1. CH471121 Genomic DNA. Translation: EAW53598.1. BC000776 mRNA. Translation: AAH00776.2. BC045111 mRNA. Translation: AAH45111.1. |
| IPI | IPI00644025. IPI00645484. |
| RefSeq | NP_055664.3. NM_014849.3. |
| UniGene | Hs.516153. |
3D structure databases | |
| ProteinModelPortal | Q7L0J3. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q7L0J3. 3 interactions. |
| STRING | 9606.ENSP00000358142. |
PTM databases | |
| PhosphoSite | Q7L0J3. |
Polymorphism databases | |
| DMDM | 74749878. |
Proteomic databases | |
| PaxDb | Q7L0J3. |
| PeptideAtlas | Q7L0J3. |
| PRIDE | Q7L0J3. |
Protocols and materials databases | |
| DNASU | 9900. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000369145; ENSP00000358141; ENSG00000159164. ENST00000369146; ENSP00000358142; ENSG00000159164. ENST00000581609; ENSP00000463016; ENSG00000265307. ENST00000584087; ENSP00000462467; ENSG00000265307. |
| GeneID | 9900. |
| KEGG | hsa:9900. |
| UCSC | uc001etg.3. human. |
Organism-specific databases | |
| CTD | 9900. |
| GeneCards | GC01M149874. |
| HGNC | HGNC:20566. SV2A. |
| HPA | CAB002226. HPA007863. |
| MIM | 185860. gene. |
| neXtProt | NX_Q7L0J3. |
| PharmGKB | PA128394564. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0477. |
| HOVERGEN | HBG053967. |
| InParanoid | Q7L0J3. |
| KO | K06258. |
| OMA | LTTMPES. |
| OrthoDB | EOG4K0QMZ. |
| PhylomeDB | Q7L0J3. |
Gene expression databases | |
| Bgee | Q7L0J3. |
| CleanEx | HS_SV2A. |
| Genevestigator | Q7L0J3. |
| GermOnline | ENSG00000159164. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR001646. 5peptide_repeat. IPR011701. MFS. IPR020846. MFS_dom. IPR016196. MFS_dom_general_subst_transpt. IPR005828. Sub_transporter. IPR005829. Sugar_transporter_CS. IPR022308. SV2. [Graphical view] |
| PANTHER | PTHR24065. PTHR24065. 1 hit. |
| Pfam | PF07690. MFS_1. 1 hit. PF13599. Pentapeptide_4. 1 hit. PF00083. Sugar_tr. 1 hit. [Graphical view] |
| SUPFAM | SSF103473. MFS_gen_substrate_transporter. 2 hits. |
| TIGRFAMs | TIGR01299. synapt_SV2. 1 hit. |
| PROSITE | PS50850. MFS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChEMBL | CHEMBL1998. |
| ChiTaRS | SV2A. human. |
| DrugBank | DB01202. Levetiracetam. |
| GenomeRNAi | 9900. |
| NextBio | 37327. |
| SOURCE | Search... |
Entry information
| Entry name | SV2A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q7L0J3 Secondary accession number(s): D3DUZ7 Q9BVZ9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
